J 10.9, benzylic CH2), 4.74 (2H, dd, J 3.0 and 9.6, CHPh), 6.59
(2H, s, HOArH), 7.33–7.41 (10H, m, C6H5) and 7.96 (1H, s,
OH) (Found: Mϩ, 522.2597. C31H38O7 requires M, 522.2618).
with CAN (2.49 g, 4.53 mmol) in acetonitrile gave the quinone
derivative (692 mg, 84%) as a yellow oil after silica gel chrom-
atography (chloroform); δH(CDCl3) 1.02 (6H, d, J 6.4, CH3),
3.14 (2H, dd, J 5.9 and 9.4, OCH2), 3.26 (2H, dd, J 5.9 and 9.4,
OCH2), 3.57–3.67 (4H, m, OCH2 and CHMe), 3.72 (2H, dd, J
8.4 and 11.7, OCH2), 4.52 (2H, d, J 14.8 benzylic CH2), 4.54
(2H, dd, J 2.5 and 8.4, CHPh), 4.67 (2H, d, J 14.8 benzylic
CH2), 6.79 (2H, s, the quinone moiety CH) and 7.28–7.38 (10H,
m, C6H5). Treatment of the quinone derivative (690 mg, 1.36
mmol) with 2,4-dinitrophenylhydrazine (1.01 g, 5.12 mmol)
gave (R,S,S,R)-2 (788 mg, 84%) as a red amorphous solid after
silica gel column chromatography [hexane–ethyl acetate (2:1)]
(4R,8S,10S,14R)-21-Hydroxy-19-methoxy-8,10-dimethyl-4,14-
diphenyl-3,6,9,12,15-pentaoxabicyclo[15.3.1]henicosane-1(21),
17,19-triene 27
In a manner similar to that described for the preparation of
(S,S,S,S)-18, treatment of (R,S,S,R)-25 (437 mg, 0.814 mmol)
with sodium ethanethiolate gave (R,S,S,R)-27 (281 mg, 66%) as
a colourless viscous oil after silica gel chromatography [hexane–
ethyl acetate (3:1)]; [α]D22 Ϫ108 (c 0.161, CHCl3); νmax(neat film)/
cmϪ1 3400, 2900, 1605, 1480, 1450, 1240, 1090, 762 and 705;
δH(CDCl3) 1.17 (6H, d, J 6.3, CH3), 3.41–3.73 (8H, m, OCH2),
3.69 (3H, s, OCH3), 4.04–4.16 (2H, m, CHMe), 4.57 (2H, d,
J 11.2, benzylic CH2), 4.64 (2H, d, J 11.2, benzylic CH2), 4.69
(2H, dd, J 2.8 and 10.1, CHPh), 6.59 (2H, s, HOArH), 7.32–
7.40 (10H, m, C6H5) and 7.68 (1H, s, OH); the high-resolution
mass spectrum could not be recorded because of the weak
molecular ion peak; mz (EI) (relative intensity) 522 (Mϩ, 7), 503
(7), 403 (100), 373 (15), 283 (35), 253 (37), 237 (17), 165 (35) and
151 (27).
followed by preparative recycling HPLC (chloroform); λmax
-
(CHCl3)/nm 400 (ε 2.46 × 104); νmax(KBr)/cmϪ1 3250, 2850,
1590, 1530, 1460, 1338, 1290, 1125, 900, 830 and 700;
δH(CDCl3), 1.16 (6H, d, J 6.3, CH3), 3.28 (2H, dd, J 7.3 and 8.9,
OCH2CHMe), 3.54 (2H, dd, J 4.0 and 8.9, OCH2CHMe), 3.70
(2H, dd, J 8.9 and 11.2, OCH2CHPh), 3.77 (2H, dd, J 3.0 and
11.2, OCH2CHPh), 4.00–4.70 (2H, m, CHMe), 4.68 (2H, dd
J 3.0 and 8.9 CHPh), 4.82 (2H, d, J 10.6, benzylic CH2), 4.87
(2H, d J 10.6, benzylic CH2), 7.29–7.41 (10H, m, C6H5), 7.81
[1H, d, J 8.9, (NO2)2ArH], 7.84 (2H, s, HOArH), 8.48 [1H, dd,
J 2.5 and 8.9, (NO2)2ArH], 8.75 [1H, d, J 2.5, (NO2)2ArH] and
9.53 (1H, s, OH) (Found: C, 62.63; H, 5.6; N, 8.21. C36H38O10N4
requires C, 62.97; H, 5.58; N, 8.16%).
(5S,8S,10S,13S)-19-(2Ј,4Ј-Dinitrophenylazo)-21-hydroxy-8,10-
dimethyl-5,13-diphenyl-3,6,9,12,15-pentaoxabicyclo[15.3.1]-
henicosane-1(21),17,19-triene 1
A solution of (S,S,S,S)-18 (317 mg, 0.607 mmol) in acetonitrile
(30 cm3) was added to a solution of CAN (1.03 g, 1.87 mmol) in
acetonitrile (12 cm3). The mixture was stirred for 2 h at room
temperature and then cooled to 0–5 ЊC, when it was treated with
water and extracted with ethyl acetate. The combined extracts
were washed with water, dried (MgSO4) and evaporated under
reduced pressure. The residue was chromatographed on silica
gel to give the quinone derivative (279 mg, 91%) (chloroform)
as a yellow oil; δH(CDCl3) 1.04 (6H, d, J 6.3, CH3), 3.10 (2H,
dd, J 2.5 and 9.7, OCH2), 3.28 (2H, dd, J 9.4 and 9.7, OCH2),
3.72 (2H, dd, J 8.9 and 11.9, OCH2), 3.75 (2H, dd, J 2.0 and
11.9, OCH2), 3.81–3.87 (2H, m, CHMe), 4.35 (2H, d, J 15.2
benzylic CH2), 4.45 (2H, dd, J 2.0 and 8.9, CHPh), 4.38 (2H, d,
J 15.2 benzylic CH2), 6.79 (2H, s, the quinone moiety CH) and
7.28–7.37 (10H, m, C6H5). To a solution of the quinone deriv-
ative (275 mg, 0.543 mmol) in a mixture of methylene dichlor-
ide (12 cm3) and ethanol (12 cm3) was added a solution of 2,4-
dinitrophenylhydrazine (545 mg, 2.75 mmol) in a mixture of
ethanol (12 cm3) and conc. H2SO4 (2 cm3). The mixture was
stirred for 1.5 h at room temperature after which it was diluted
with water and extracted with chloroform. The combined
extracts were washed with aq. sodium hydrogen carbonate and
water, dried (MgSO4) and evaporated under reduced pressure.
The residue was chromatographed on silica gel to give a solid
[hexane–ethyl acetate (2:1)], which was further purified by
preparative recycling HPLC (JAIGEL 1H and JAIGEL 2H
column, chloroform) to give (S,S,S,S)-1 (308 mg, 81%) as a
red amorphous solid; λmax(CHCl3)/nm 405 (ε 2.34 × 104);
νmax(KBr)/cmϪ1 3250, 2860, 1600, 1535, 1348, 1295, 1130, 1115,
905, 830, 760 and 700; δH(CDCl3) 1.12 (6H, d, J 6.6, CH3), 3.27
(2H, dd, J 2.5 and 10.3, OCH2CHMe), 3.46 (2H, dd, J 9.1 and
9.5, OCH2CHPh), 3.70 (2H, t, J 10.3, OCH2CHMe), 3.84 (2H,
dd, J 2.6 and 9.5, OCH2CHPh), 4.11–4.50 (2H, m, CHMe),
4.60 (2H, dd, J 2.5 and 9.1 CHPh), 4.78 (2H, d, J 11.1, benzylic
CH2), 4.88 (2H, d, J 11.1, benzylic CH2), 7.28–7.37 (10H, m,
C6H5), 7.83 [1H, d, J 8.9, (NO2)2ArH], 7.85 (2H, s, HOArH),
8.49 [1H, dd, J 2.3 and 8.9, (NO2)2ArH], 8.75 [1H, d, J 2.3,
(NO2)2ArH] and 9.45 (1H, s, OH) (Found: C, 62.64; H, 5.6; N,
8.22. C36H38O10N4 requires C, 62.97; H, 5.58; N, 8.16%).
(4S,8S,10S,14S)-19-(2Ј,4Ј-Dinitrophenylazo)-21-hydroxy-8,10-
dimethyl-4,14-diphenyl-3,6,9,12,15-pentaoxabicyclo[15.3.1]-
henicosane-1(21),17,19-triene 3
By a procedure similar to that described for the preparation of
(S,S,S,S)-1, oxidation of (S,S,S,S)-26 (317 mg, 0.607 mmol)
with CAN (1.03 g, 1.87 mmol) in acetonitrile followed by silica
gel chromatography of the products gave the quinone derivative
(289 mg, 94%) (chloroform) as a yellow oil; δH(CDCl3) 1.10
(6H, d, J 6.3, CH3), 3.27–3.61 (8H, m, OCH2), 3.76–3.83 (2H,
m, CHMe), 4.30 (2H, d, J 15.2 benzylic CH2), 4.64 (2H,
dd, J 4.0 and 7.9, CHPh), 4.79 (2H, d, J 15.2 benzylic CH2),
6.76 (2H, s, the quinone moiety CH) and 7.29–7.42 (10H, m,
C6H5). Treatment of the quinone derivative (279 mg, 0.551
mmol) with 2,4-dinitrophenylhydrazine (861 mg, 4.35 mmol)
gave (S,S,S,S)-3 (487 mg, 81%) as a red amorphous solid after
silica gel column chromatography [hexane–ethyl acetate (2:1)]
followed by preparative recycling HPLC (chloroform);
λmax(CHCl3)/nm 406 (ε 2.38 × 104); νmax(KBr)/cmϪ1 3250, 2850,
1590, 1535, 1345, 1290, 1110, 1030, 900, 835, 758 and 700;
δH(CDCl3) 1.22 (6H, d, J 6.6, CH3), 3.40 (2H, dd, J 4.5 and 9.6,
OCH2CHMe), 3.55 (2H, dd, J 2.7 and 10.9, OCH2CHPh), 3.69
(2H, t, J 9.6, OCH2CHMe), 3.71 (2H, dd, J 5.8 and 10.9,
OCH2CHPh), 4.28–4.39 (2H, m, CHMe), 4.61 (2H, dd, J 2.7
and 10.9 CHPh), 4.61 (2H, d, J 11.1, benzylic CH2), 4.71 (2H,
d, J 11.1, benzylic CH2), 7.34–7.47 (10H, m, C6H5), 7.78 [1H, d,
J 8.9, (NO2)2ArH], 7.71 (2H, s, HOArH), 8.46 [1H, dd, J 2.5,
8.9, (NO2)2ArH], 8.73 [1H, d, J 2.5, (NO2)2ArH] and 9.53 (1H,
s, OH) (Found: C, 62.79; H, 5.5; N, 8.05. C36H38O10N4 requires
C, 62.97; H, 5.58; N, 8.16%).
(4R,8S,10S,14R)-19-(2Ј,4Ј-Dinitrophenylazo)-21-hydroxy-8,10-
dimethyl-4,14-diphenyl-3,6,9,12,15-pentaoxabicyclo[15.3.1]-
henicosane-1(21),17,19-triene 4
By a procedure similar to that described for the preparation of
(S,S,S,S)-1, oxidation of (R,S,S,R)-27 (279 mg, 0.534 mmol)
with CAN (888 mg, 1.62 mmol) in acetonitrile gave the quinone
derivative (228 mg, 84%) as a yellow oil after silica gel chrom-
atography (chloroform); δH(CDCl3) 1.10 (6H, d, J 6.2, CH3),
3.28 (2H, dd, J 4.6 and 9.3, OCH2), 3.43 (2H, dd, J 6.3 and 9.3,
OCH2), 3.49–3.63 (4H, m, OCH2), 3.67–3.74 (2H, m, CHMe),
4.42 (2H, d, J 15.2 benzylic CH2), 4.66 (2H, dd, J 2.7 and 8.9,
CHPh), 4.73 (2H, d, J 14.8 benzylic CH2), 6.75 (2H, s, the
quinone moiety CH) and 7.31–7.38 (10H, m, C6H5). Treatment
of the quinone derivative (220 mg, 0.436 mmol) with 2,4-
(5R,8S,10S,13R)-19-(2Ј,4Ј-Dinitrophenylazo)-21-hydroxy-8,10-
dimethyl-5,13-diphenyl-3,6,9,12,15-pentaoxabicyclo[15.3.1]-
henicosane-1(21),17,19-triene 2
By a procedure similar to that described for the preparation of
(S,S,S,S)-1, oxidation of (R,S,S,R)-19 (776 mg, 1.48 mmol)
J. Chem. Soc., Perkin Trans. 1, 1997
3235